(Q33418532)
Statements
1 reference
A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK study (English)
1 reference
Lynley V Marshall
Andrew D J Pearson
Bruce Morland
Martin Elliott
Quentin Campbell-Hewson
Sarah E R Halford
Gary Acton
Philip Ross
Shamim Kazmi-Stokes
Victoria Lock
Ana Rodriguez
John F Lyons
Melanie J Griffin
4 November 2014
1 reference